Multiple Manufacturers

Dacarbazine

Manufacturer:

Multiple Manufacturers

Dacarbazine HCPCS:

J9130

HCPCS Code Descriptor:

Dacarbazine, 100 mg

Category:

J Code

Dacarbazine NDCs:

00703-5075-01, 63323-0128-20, 00143-9245-10, 63323-0127-10

Primary Type:

Oncology

Generic/Specialty Status:

Multi-Source

Package Type:

Vial

Route of Administration:

Intravenous

Dacarbazine CPT Codes:

Potential CPT administration codes for Dacarbazine can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Dacarbazine:

Dacarbazine is a medication manufactured by multiple manufacturers and aligned to the J Code: J9130. Dacarbazine is administered via the intravenous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J9130 Added Date:

January 1, 1986

J9130 Effective Date:

January 1, 2004

J9130 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Dacarbazine billing and coding information.
Our team did not identify a source for Dacarbazine patient assistance information. Please reach out to our team if you feel that this is a mistake.
Dacarbazine prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for Dacarbazine. Please check back in a few weeks.